A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies
- 11 March 2008
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 105 (10), 3739-3744
- https://doi.org/10.1073/pnas.0800255105
Abstract
Most antibodies induced by HIV-1 are ineffective at preventing initiation or spread of infection because they are either nonneutralizing or narrowly isolate-specific. Rare, “broadly neutralizing” antibodies have been detected that recognize relatively conserved regions on the envelope glycoprotein. Using stringently characterized, homogeneous preparations of trimeric HIV-1 envelope protein in relevant conformations, we have analyzed the molecular mechanism of neutralization by two of these antibodies, 2F5 and 4E10. We find that their epitopes, in the membrane-proximal segment of the envelope protein ectodomain, are exposed only on a form designed to mimic an intermediate state during viral entry. These results help explain the rarity of 2F5- and 4E10-like antibody responses and suggest a strategy for eliciting them.This publication has 37 references indexed in Scilit:
- Structural definition of a conserved neutralization epitope on HIV-1 gp120Nature, 2007
- Exposure of the Membrane-Proximal External Region of HIV-1 gp41 in the Course of HIV-1 Envelope Glycoprotein-Mediated FusionBiochemistry, 2007
- Restraining the conformation of HIV-1 gp120 by removing a flexible loopThe EMBO Journal, 2006
- Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusionProceedings of the National Academy of Sciences of the United States of America, 2006
- A Chimeric Protein of Simian Immunodeficiency Virus Envelope Glycoprotein gp140 andEscherichia coliAspartate TranscarbamoylaseJournal of Virology, 2004
- Binding of the 2F5 Monoclonal Antibody to Native and Fusion-Intermediate Forms of Human Immunodeficiency Virus Type 1 gp41: Implications for Fusion-Inducing Conformational ChangesJournal of Virology, 2004
- Novel Therapies Based on Mechanisms of HIV-1 Cell EntryThe New England Journal of Medicine, 2003
- Antibody neutralization and escape by HIV-1Nature, 2003
- Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectinJournal of General Virology, 2003
- Genetic Evidence that Interhelical Packing Interactions in the gp41 Core Are Critical for Transition of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein to the Fusion-Active StateJournal of Virology, 2002